1-4 of 4
Rinath Jeselsohn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR012: KAT6A/B and Menin-MLL complexes coordinately regulate estrogen receptor-driven gene expression programs in breast cancer

Sarah Naomi Olsen, Bryn Anderson, Charles Hatton, Rinath Jeselsohn, Myles Brown, Eneda Toska, Scott Armstrong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (6_Supplement): PR012.
https://doi.org/10.1158/1538-8514.SYNTHLETH24-PR012
Published: 10 June 2024
View article titled, Abstract PR012: KAT6A/B and Menin-MLL complexes coordinately regulate estrogen receptor-driven gene expression programs in breast cancer
Journal Articles

Abstract A025: KAT6A/B and Menin-MLL complexes coordinately regulate estrogen receptor-driven gene expression programs in breast cancer

Sarah Naomi Olsen, Bryn Anderson, Charles Hatton, Rinath Jeselsohn, Myles Brown, Eneda Toska, Scott Armstrong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (6_Supplement): A025.
https://doi.org/10.1158/1538-8514.SYNTHLETH24-A025
Published: 10 June 2024
View article titled, Abstract A025: KAT6A/B and Menin-MLL complexes coordinately regulate estrogen receptor-driven gene expression programs in breast cancer
Journal Articles

The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor

Kaitlyn J. Andreano, Jennifer G. Baker, Sunghee Park, Rachid Safi, Sandeep Artham, Steffi Oesterreich, Rinath Jeselsohn, Myles Brown, Sarah Sammons, Suzanne E. Wardell, Ching-yi Chang, John D. Norris, Donald P. McDonnell
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (7): 1395–1405.
https://doi.org/10.1158/1535-7163.MCT-19-1148
Published: 02 July 2020
View article titled, The Dysregulated Pharmacology of Clinically Relevant <em>ESR1</em> Mutants is Normalized by Ligand-activated WT Receptor
Open the PDF for The Dysregulated Pharmacology of Clinically Relevant <em>ESR1</em> Mutants is Normalized by Ligand-activated WT Receptor in another window
Includes: Supplementary data
Journal Articles

Abstract PR06: CRISPR screens identified drivers of endocrine resistance and synthetic lethal vulnerabilities in breast cancer

Tengfei Xiao, Wei Li, Xiaoqing Wang, Han Xu, Qiu Wu, Peng Jiang, Jixin Yang, Teng Fei, Chongzhi Zang, Qi Liao, Jonathan Rennhack, Eran Andrechek, Nanlin Li, Rinath Jeselsohn, Shirley X. Liu, Myles Brown
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (10_Supplement): PR06.
https://doi.org/10.1158/1538-8514.SYNTHLETH-PR06
Published: 02 October 2017
View article titled, Abstract PR06: CRISPR screens identified drivers of endocrine resistance and synthetic lethal vulnerabilities in breast cancer